The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Ontology highlight
ABSTRACT: The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
PROVIDER: PRJNA704856 | ENA |
REPOSITORIES: ENA
ACCESS DATA